Isabel Arrillaga-Romany, MD, PhD @MGHNeuroOnc @Oncoceutics explains how this is going to affect clinicians today and what clinicians should know about patients with the H3 K27 mutation.
Content Warning: These Videos Are Intended for Doctors and Health Care Professionals.
What should clinicians know about patients with the H3 K27M mutation?
ONC201 in adult recurrent GBM
What data has come out of the ONC201 in adult recurrent glioblastoma trials?
ONC201 recurrent GBM: How can we get access to this drug?
ONC201 in adult recurrent GBM: What’s next?